INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
2.160
-0.070 (-3.14%)
At close: Aug 20, 2026, 4:00 PM EDT
2.180
+0.020 (0.93%)
After-hours: Aug 20, 2026, 6:38 PM EDT
INmune Bio Revenue
In the year 2025, INmune Bio had annual revenue of $50.00K with 257.14% growth.
Revenue (ttm)
$50.00K
Revenue Growth
+257.14%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
21
Market Cap
59.95M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 50.00K | 36.00K | 257.14% |
| Dec 31, 2024 | 14.00K | -141.00K | -90.97% |
| Dec 31, 2023 | 155.00K | -219.00K | -58.56% |
| Dec 31, 2022 | 374.00K | 193.00K | 106.63% |
| Dec 31, 2021 | 181.00K | 170.00K | 1,545.45% |
| Dec 31, 2020 | 11.00K | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Heron Therapeutics | 151.18M |
| Xilio Therapeutics | 64.09M |
| BioStem Technologies | 34.59M |
| MindWalk Holdings | 11.43M |
| RenovoRx | 1.98M |
| MediciNova | 920.48K |
| ImageneBio | 800.00K |
| eXoZymes | -700.00 |
INMB News
- 14 days ago - INmune Bio Earnings Call Transcript: Q2 2026 - Transcripts
- 14 days ago - INmune Bio Quarterly report: Q2 2026 - Filings
- 14 days ago - INmune Bio Earnings release: Q2 2026 - Filings
- 20 days ago - INmune Bio receives $4.6M in rebates from Australia, UK - TheFly
- 20 days ago - INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th - GlobeNewsWire
- 20 days ago - INmune Bio Receives R&D Rebates of Approximately $4.6 Million - GlobeNewsWire
- 21 days ago - INmune Bio Establishes Scientific Advisory Board to Support Late-Stage Development and Expansion of CORDStrom™ Platform - GlobeNewsWire
- 4 weeks ago - INmune Bio processes first umbilical cord tissue at CGT Catapult - TheFly